You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科倫藥業(002422.SZ)擬通過科倫藥研作為股權激勵實施主體 實施仿製藥業務板塊研發核心人員的股權激勵
格隆匯 05-29 22:19

格隆匯5月29日丨科倫藥業(002422.SZ)公佈,進一步建立和健全員工激勵機制鼓勵公司仿製藥業務板塊研發核心人員工作積極性,公司擬四川科倫藥物研究院有限公司(“科倫藥研)作為股權激勵實施主體實施仿製藥業務板塊研發核心人員股權激勵

此次股權激勵的激勵對象為科倫藥研、蘇州科倫藥物研究有限公司(蘇州藥研)、天津科倫藥物研究有限公司(天津藥研)級管理人員、技術骨幹及其他核心員工前述激勵對象通過持有成都藥研聚智企業管理服務合夥企業(有限合夥)成都藥研聚能企業管理服務合夥企業(有限合夥)成都藥研聚才企業管理服務合夥企業(有限合夥)成都藥研聚德企業管理服務合夥企業(有限合夥)等四個合夥企業(暫定名員工持股平台)相應份額間接持有科倫藥研股權的方式參與此次股權激勵

科倫藥研、蘇州藥研及天津藥研的核心員工持有員工持股平台的相應份額員工持股平台的激勵份額來源於員工持股平台以3000萬元的對價合計受讓公司持有的科倫藥研30%的股權。

次股權轉讓完成後,公司將持有科倫藥研60%的股權,員工持股平台將持有科倫藥研30%的股權,自然人王晶翼將持有10%的股權

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account